Literature DB >> 15630237

Lentinan from shiitake mushroom (Lentinus edodes) suppresses expression of cytochrome P450 1A subfamily in the mouse liver.

Takashi Okamoto1, Rie Kodoi, Yuji Nonaka, Itsuko Fukuda, Takashi Hashimoto, Kazuki Kanazawa, Masashi Mizuno, Hitoshi Ashida.   

Abstract

Induction of xenobiotics metabolizing enzymes is related to the formation and chemoprevention of cancer. Since cytochrome P450s (CYPs) including CYP1A subfamily metabolize certain pro-carcinogens to their ultimate forms, down-regulation of CYP1As by food factors leads to the prevention of cancer. Mushroom polysaccharides, especially beta-glucans such as lentinan from Lentinus edodes, possess the anti-tumor and immunomodulating activities through the cytokine production from immunocytes. Recent our studies have demonstrated that lentinan suppresses hepatic CYP1As expression in the both constitutive and inducible levels through the production of tumor necrosis factor-alpha and an increase in the DNA-binding activity of nuclear factor-kappaB. This paper discusses on the effective lentinan dosage and route of administration for suppression of CYP1As.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15630237     DOI: 10.1002/biof.552210180

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  7 in total

Review 1.  Possible mechanisms of action of mushroom-derived glucans on inflammatory bowel disease and associated cancer.

Authors:  Betty Schwartz; Yitzhak Hadar
Journal:  Ann Transl Med       Date:  2014-02

2.  Technological and sensorial role of yeast β-glucan in meat batter reformulations.

Authors:  Paul Mihai Apostu; Tamara Elena Mihociu; Anca Ioana Nicolau
Journal:  J Food Sci Technol       Date:  2017-07-12       Impact factor: 2.701

Review 3.  Effects of Non-Starch Polysaccharides on Inflammatory Bowel Disease.

Authors:  Ying Nie; Qinlu Lin; Feijun Luo
Journal:  Int J Mol Sci       Date:  2017-06-27       Impact factor: 5.923

Review 4.  Clinical and Physiological Perspectives of β-Glucans: The Past, Present, and Future.

Authors:  Khawaja Muhammad Imran Bashir; Jae-Suk Choi
Journal:  Int J Mol Sci       Date:  2017-09-05       Impact factor: 5.923

Review 5.  Potential of Mushroom Compounds as Immunomodulators in Cancer Immunotherapy: A Review.

Authors:  Peter Amwoga Ayeka
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-22       Impact factor: 2.629

6.  Metabolomics insights into the modulatory effects of long-term compound polysaccharide intake in high-fat diet-induced obese rats.

Authors:  Mingyi Chen; Biyu Lu; Yuan Li; Yuanyuan Wang; Haihui Zheng; Danmin Zhong; Ziqiong Liao; Mengxia Wang; Fangli Ma; Qiongfeng Liao; Zhiyong Xie
Journal:  Nutr Metab (Lond)       Date:  2018-01-23       Impact factor: 4.169

Review 7.  Effects of Medicinal Fungi-Derived β-Glucan on Tumor Progression.

Authors:  Vaclav Vetvicka; Tamara V Teplyakova; Alexandra B Shintyapina; Tatiana A Korolenko
Journal:  J Fungi (Basel)       Date:  2021-03-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.